Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons

Core Insights - Smith+Nephew has signed an exclusive US distribution agreement with RMR Ortho to incorporate the A'TOMIC™ Nitinol Fixation System into its Trauma, Foot & Ankle, and Hand & Wrist portfolio, aimed at enhancing implant integrity and patient comfort [1][4] Group 1: Partnership and Product Details - The partnership with RMR Ortho enhances Smith+Nephew's fixation portfolio by adding a dynamic compression fixation solution that complements existing technologies [4] - The A'TOMIC Nitinol Fixation System utilizes proprietary manufacturing methods and unique nitinol properties to provide compressive fixation implants designed for stability in fusion, fracture, and osteotomy sites [4] - This collaboration is expected to deepen surgeon engagement and expand participation in high-frequency fracture and arthrodesis procedures [4][5] Group 2: Company Overview - Smith+Nephew is a global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue, with a mission to restore people's bodies and self-belief [8] - The company operates in over 100 countries and reported annual sales of $5.8 billion in 2024, positioning itself as a constituent of the FTSE100 [9]